For example, it was reported that MeCP2 is elevated in glioma, and the overexpression of MeCP2 represses invasion, migration and proliferation by regulating the extracellular signal‐regulated kinase pathway in glioma [25]. This evidence concerns the gene MECP2 and central nervous system cancer.